Selected article for: "acute sars cov respiratory syndrome coronavirus and adequately manage"
Author: Rahmawati, Putu Lohita; Tini, Kumara; Susilawathi, Ni Made; Wijayanti, IA Sri; Samatra, DPG Purwa
Title: Pathomechanism and Management of Stroke in COVID-19: Review of Immunopathogenesis, Coagulopathy, Endothelial Dysfunction, and Downregulation of ACE2
  • Cord-id: cf8n9dg8
  • Document date: 2021_3_18
    • ID: cf8n9dg8
    Snippet: Coronavirus disease 2019 (COVID-19) can reportedly manifest as an acute stroke, with most cases presenting as large vessel ischemic stroke in patients with or without comorbidities. The exact pathomechanism of stroke in COVID-19 remains ambiguous. The findings of previous studies indicate that the most likely underlying mechanisms are cerebrovascular pathological conditions following viral infection, inflammation-induced endothelial dysfunction, and hypercoagulability. Acute endothelial damage d
    Document: Coronavirus disease 2019 (COVID-19) can reportedly manifest as an acute stroke, with most cases presenting as large vessel ischemic stroke in patients with or without comorbidities. The exact pathomechanism of stroke in COVID-19 remains ambiguous. The findings of previous studies indicate that the most likely underlying mechanisms are cerebrovascular pathological conditions following viral infection, inflammation-induced endothelial dysfunction, and hypercoagulability. Acute endothelial damage due to inflammation triggers a coagulation cascade, thrombosis propagation, and destabilization of atherosclerosis plaques, leading to large-vessel occlusion and plaque ulceration with concomitant thromboemboli, and manifests as ischemic stroke. Another possible mechanism is the downregulation of angiotensin-converting enzyme 2 as the target action of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Acute stroke management protocols need to be modified during the COVID-19 pandemic in order to adequately manage stroke patients with COVID-19.

    Search related documents:
    Co phrase search for related documents
    • ace angiotensin and acute management: 1, 2, 3, 4, 5
    • ace angiotensin and acute phase: 1, 2, 3, 4, 5
    • ace angiotensin and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace angiotensin and acute st elevation myocardial infarction: 1
    • ace angiotensin and acute stroke: 1, 2, 3, 4
    • ace angiotensin and acute stroke management: 1
    • ace angiotensin ii and activation production: 1, 2, 3
    • ace angiotensin ii and acute management: 1, 2
    • ace angiotensin ii and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace inhibition and activation production: 1
    • ace inhibition and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5
    • ace inhibitor and activation production: 1
    • ace inhibitor and acute phase: 1
    • ace inhibitor and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • ace inhibitor and acute st elevation myocardial infarction: 1
    • activation production and acute phase: 1, 2, 3, 4, 5, 6
    • activation production and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • activation production and acute stroke: 1